查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1512707

醫療用拋棄式市場:市場規模&預測，2024年～2032年

Medical Disposable Market : Market Size & Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 110 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

根據 Polaris Market Research 發布的一項新研究，到 2032 年，一次性醫療用品市場預計將達到 21,428 億美元以上。 2023年，藥物輸送在全球醫療一次性用品產業中佔據主導地位。預計到 2023 年，亞太地區將成為全球市場收入的主要貢獻者。醫院、門診設施和其他醫療保健提供者的一次性醫療用品勢頭強勁。醫療一次性用品市場主要是由老年人口的增加、限制感染源的需求不斷增加、更好的性能、成本可靠性、保質期和材料推動的。可重複使用的器具有多種類型，被認為相對便宜，全球主要參與者增加產量也可能影響未來幾年的市場成長。

技術先進產品的增加和持續的研發也將推動市場成長。此外，提高患者對使用一次性醫療設備的認識也將推動未來幾年的市場成長。此外，全球慢性病盛行率的不斷上升也可能推動未來幾年的市場成長。

依產品類型，一次性醫療用品市場分為傷口處理、藥物傳輸、透析、非織造失禁、呼吸用品、診斷和實驗室以及滅菌。同樣，依原料劃分，市場分為紙張和紙板、塑膠樹脂、不織布、金屬、玻璃和橡膠。塑膠樹脂是成長最快的領域，因為它們有多種應用。醫療一次性設備的最終使用者包括醫院、門診/初級保健機構和家庭保健機構。

北美在 2023 年是一次性醫療用品市場收入最高的地區，預計在預測期內將成為全球領先地區。對醫療保健設施的需求增加、老年人口不斷增長以及美國和加拿大主要參與者的持續併購。亞太地區也將在未來幾年推動市場成長。該地區國家的新興市場開發將是預測期內推動市場成長的關鍵因素。

醫療一次性用品市場的主要參與者包括Johnson &Johnson Services, Inc.，3M，Abbott Laboratories，Medtronic Plc.，B． Braun Melsungen AG，Bayer AG，Smith and Nephew Plc.，Medline Industries, Inc.，Cardinal Health，Becton, Dickinson &Company等。為了與產業各公司，消費者的需求和要求的高漲對應，簽訂其他公司的合作和夥伴關係契約開發·發售著新產品。

目錄

第1章 概要與範圍

  • 調查目標和範圍
  • 調查的前提條件
  • 調查手法
  • 要點
  • 利害關係者

第2章 摘要整理

第3章 醫療用拋棄式的市場分析

  • 醫療用拋棄式-產業概述
  • 醫療用拋棄式-生態系統分析
  • 醫療用拋棄式市場動態
    • 醫療用拋棄式-市場要點
      • 醫療用拋棄式的市場推動要素分析
      • 醫療用拋棄式市場阻礙因素/課題分析
      • 醫療用拋棄式的市場機會分析
  • 產業分析- 波特的五力分析
    • 供應商談判力
    • 買方議價能力
    • 替代品的威脅
    • 新加入廠商的威脅
    • 競爭的程度
  • 醫療用拋棄式市場PEST分析
  • 醫療用拋棄式市場價值鏈分析
  • 醫療用拋棄式趨勢
  • 競爭排行榜分析

第4章 醫療用拋棄式的市場規模與預測:各治療類型，2019年～2032年

  • 主要調查結果
  • 創傷管理
  • 藥物輸送
  • 透析
  • Nonwoven Incontinence
  • 呼吸系統用品
  • 診斷及檢驗
  • 殺菌

第5章 醫療用拋棄式的市場規模與預測:各原材料類型，2019年～2032年

  • 主要調查結果
  • 紙張及厚紙板
  • 塑膠樹脂
  • 不織布材料
  • 金屬
  • 玻璃
  • 橡膠

第6章 醫療用拋棄式的市場規模與預測:各最終用途，2019年～2032年

  • 主要調查結果
  • 醫院
  • 門診病人/基層護理設施
  • 家庭醫療保健

第7章 醫療用拋棄式的市場規模與預測:各地區，2019年～2032年

  • 主要調查結果
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 新加坡
    • 馬來西亞
    • 澳洲
    • 其他亞太地區
  • 南美
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他的南美
  • 中東·非洲

第8章 企業簡介

  • Johnson & Johnson Services, Inc.
  • 3M
  • Abbott Laboratories.
  • Braun Melsungen AG
  • Bayer AG
  • Smith and Nephew Plc
  • Medline Industries, Inc.
  • Cardinal Health.
  • Becton, Dickinson & Company
  • Medtronic Plc.gk
簡介目錄
Product Code: PM1572

The medical disposable market is anticipated to reach over USD 2142.80 billion by 2032 according to a new research published by Polaris Market Research. In 2023, the drug delivery dominated the worldwide medical disposable industry. Asia-Pacific is anticipated to be the leading contributor to the global market revenue in 2023. The upward momentum of medical disposable in the hospitals, outpatient facility and other healthcare providers. The medical disposable market is primarily driven by increasing number of elderly populations, increasing need to limit the causes of infection, better performance, cost reliability, shelf life, and material. The reusable devices are considered to be relatively inexpensive in many different types, and increasing volume of production by the key players globally would also influence the market growth in the coming years.

Increasing number of technologically advanced products, and continuous research and development to also drive the market growth. Furthermore, increasing awareness in the patients for the use of medical disposable devices to also boost the market growth in the coming years. Also, increasing number of chronic diseases across the globe would also boost the market growth in the coming years.

Based on the product type the medical disposable market is segmented as Wound Management, Drug Delivery, Dialysis, Nonwoven Incontinence, Respiratory Supplies, Diagnostic and Laboratory, and Sterilization. Similarly, on the basis of raw material, the market is segmented as Paper and Paperboard, Plastic Resin, Nonwoven Material, Metals, Glass, and Rubber. Plastic Resin is expected to be the fastest growing segment owning to its various application. End user for the medical disposable devices include Hospitals, Outpatient/Primary Care Facilities, and Home Healthcare.

North America generated the highest revenue in the Medical Disposable market in 2023, and is expected to be the leading region globally during the forecast period. Increasing demand healthcare facilities, increasing number of geriatric populations, and continuous mergers and acquisitions of the key players in the U.S. and Canada. Asia Pacific to also boost the market growth in coming years. The developing healthcare infrastructure of the countries in this region to be the major factor promoting the growth of this market during the forecast period.

The key players operating in the Medical Disposable market include Johnson & Johnson Services, Inc., 3M, Abbott Laboratories, Medtronic Plc., B. Braun Melsungen AG, Bayer AG, Smith and Nephew Plc., Medline Industries, Inc., Cardinal Health, and Becton, Dickinson & Company. The industry participants launch novel products with collaboration and partnership agreements with other companies to innovate and launch new products to meet the increasing needs and requirements of consumers.

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research Methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-away
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market Definition
  • 2.2. Market Segmentation

3. Medical Disposable Market Insights

  • 3.1. Medical disposable - Industry snapshot
  • 3.2. Medical disposable - Ecosystem analysis
  • 3.3. Medical disposable Market Dynamics
    • 3.3.1. Medical disposable - Market Forces
      • 3.3.1.1. Medical disposable Market Driver Analysis
      • 3.3.1.2. Medical disposable Market Restraint/Challenges analysis
      • 3.3.1.3. Medical disposable Market Opportunity Analysis
  • 3.4. Industry analysis - Porter's five force
    • 3.4.1. Bargaining power of supplier
    • 3.4.2. Bargaining power of buyer
    • 3.4.3. Threat of substitute
    • 3.4.4. Threat of new entrant
    • 3.4.5. Degree of competition
  • 3.5. Medical disposable Market PEST Analysis
  • 3.6. Medical disposable Market Value Chain Analysis
  • 3.7. Medical disposable Industry Trends
  • 3.8. Competitive Ranking Analysis

4. Medical Disposable Market Size and Forecast by Treatment Type, 2019-2032

  • 4.1. Key Findings
  • 4.2. Wound Management
  • 4.3. Drug Delivery
  • 4.4. Dialysis
  • 4.5. Nonwoven Incontinence
  • 4.6. Respiratory Supplies
  • 4.7. Diagnostic and Laboratory
  • 4.8. Sterilization

5. Medical Disposable Market Size and Forecast by Raw Material Type, 2019-2032

  • 5.1. Key Findings
  • 5.2. Paper and Paperboard
  • 5.3. Plastic Resin
  • 5.4. Nonwoven Material
  • 5.5. Metals
  • 5.6. Glass
  • 5.7. Rubber

6. Medical Disposable Market Size and Forecast by End Use, 2019-2032

  • 6.1. Key Findings
  • 6.2. Hospitals
  • 6.3. Outpatient/Primary Care Facilities
  • 6.4. Home Healthcare

7. Medical Disposable Market Size and Forecast by Region, 2019-2032

  • 7.1. Key Findings
  • 7.2. North America
    • 7.2.1. U. S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. UK
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Asia-Pacific
    • 7.4.1. China
    • 7.4.2. India
    • 7.4.3. Japan
    • 7.4.4. Singapore
    • 7.4.5. Malaysia
    • 7.4.6. Australia
    • 7.4.7. Rest of Asia-Pacific
  • 7.5. Latin America
    • 7.5.1. Mexico
    • 7.5.2. Brazil
    • 7.5.3. Argentina
    • 7.5.4. Rest of LATAM
  • 7.6. Middle East & Africa

8. Company Profiles

  • 8.1. Johnson & Johnson Services, Inc.
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Developments
  • 8.2. 3M
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Developments
  • 8.3. Abbott Laboratories.
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Developments
  • 8.4. Braun Melsungen AG
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Developments
  • 8.5. Bayer AG
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Developments
  • 8.6. Smith and Nephew Plc
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Developments
  • 8.7. Medline Industries, Inc.
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Developments
  • 8.8. Cardinal Health.
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Developments
  • 8.9. Becton, Dickinson & Company
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Developments
  • 8.10. Medtronic Plc.gk
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Developments